12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several healthcare stocks experienced significant movements. Akso Health Group (AHG), Elevation Oncology (ELEV), Y-mAbs Therapeutics (YMAB), Atreca (BCEL), Alaunos Therapeutics (TCRT), and ASLAN Pharma (ASLN) saw their stock prices increase, with gains ranging from 13.77% to 29.2%. Conversely, Cyclacel Pharmaceuticals (CYCC), NexImmune (NEXI), MAIA Biotechnology (MAIA), Avalo Therapeutics (AVTX), GeneDx Hldgs (WGS), and Seelos Therapeutics (SEEL) faced declines between 12.27% and 19.4%.
January 12, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akso Health Group's stock rose by 29.2% to $1.15, with a market cap of $26.2 million.
A significant intraday increase of 29.2% is likely to draw investor attention and could indicate positive sentiment or developments, potentially leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
ASLAN Pharma's shares rose by 13.77% to $0.9, with a market cap of $14.9 million.
The 13.77% increase in ASLAN Pharma's stock price could suggest a positive market response, potentially leading to more short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Atreca's stock increased by 22.95% to $0.29, with a market cap of $11.3 million.
The significant gain of 22.95% could attract investor interest and potentially lead to further short-term appreciation in stock value.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Elevation Oncology's stock increased by 28.3% to $2.72, with a market cap of $115.3 million.
The substantial rise of 28.3% suggests a strong market reaction that could continue to positively influence the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Alaunos Therapeutics' stock increased by 20.14% to $0.17, with a market cap of $40.7 million.
A 20.14% rise in stock price indicates a positive trend that could continue in the short term, driven by investor optimism.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Y-mAbs Therapeutics' stock rose 26.69% to $9.54, with a market cap of $416.1 million.
A 26.69% increase in stock price is a strong indicator of positive investor sentiment, which may lead to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Avalo Therapeutics' shares declined by 14.56% to $5.87, with a market cap of $4.7 million.
A 14.56% decrease in Avalo Therapeutics' stock price suggests potential negative developments, which could lead to further short-term declines.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Cyclacel Pharmaceuticals' stock fell by 19.4% to $2.24, with a market cap of $2.2 million.
The significant drop of 19.4% could reflect negative sentiment or adverse events, likely leading to further short-term downward pressure on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
MAIA Biotechnology's stock declined by 16.32% to $1.18, with a market cap of $20.0 million.
The decline of 16.32% could indicate negative market sentiment or disappointing news, potentially leading to further short-term losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
NexImmune's stock decreased by 17.97% to $9.59, with a market cap of $10.1 million.
A 17.97% decline in stock price is a strong negative signal that may lead to further short-term depreciation in the stock's value.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Seelos Therapeutics' shares decreased by 12.27% to $1.43, with a market cap of $14.0 million.
The 12.27% fall in Seelos Therapeutics' stock price may reflect investor concerns, potentially leading to further short-term negative performance.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
GeneDx Hldgs' stock declined by 12.34% to $3.34, with a market cap of $86.4 million.
The 12.34% drop in GeneDx Hldgs' stock could be a reaction to unfavorable news or market conditions, possibly leading to more short-term selling.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100